Citi maintains a 'Hold' rating on Eli Lilly (NYSE: LLY). Price target lowered from $52 to $42.

Citi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE